Search Results
Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches
The Advanced Ovarian Cancer Treatment Palette: Candid Conversations on PARP Inhibitors
PARP inhibitor rechallenging in ovarian cancer
PARP inhibitors as first-line maintenance therapy in ovarian cancer
Optimizing the Use of PARP Inhibitors in Ovarian Cancer
Pharmacy Perspectives on PARP Inhibitor Therapy in Ovarian Cancer Care
The Therapeutic Potential of Novel PARP Inhibitors in the Clinic for Epithelial Ovarian Cancer
Enhancing Personalized Medicine in Ovarian Cancer: Advances in PARP Inhibition and Novel Modalities
ACT Genomics Dinner Symposium | Moving from BRCA1/2 to HRD: Beyond Woman’s Cancers
Target Practice: Understanding How PARP Inhibitors Take Aim at DDR Mutations Across Solid Tumors
Ovarian Cancer Symposium 2021: Session 4 PARP Inhibitors
